Clinical study to see the effect of Tinospora cordifolia in acute ischemic stroke patients.
Phase 3
Completed
- Conditions
- Health Condition 1: G810- Flaccid hemiplegia
- Registration Number
- CTRI/2020/11/029182
- Lead Sponsor
- Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 412
Inclusion Criteria
1.Age >= 18 years
2.Cases of Ischemic stroke with and without periventricular white matter changes.
Exclusion Criteria
1.Patients denying the consent to participate.
2.Traumatic brain injury, vascular aneurysm, arterial malformation, etc.
3.History of Central Nervous System (CNS) infections.
4.Recurrent ischemic stroke
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Functional Outcome (mRS)Timepoint: 0 days and at 90 days
- Secondary Outcome Measures
Name Time Method IHSS, MoCA, Clinical Dementia Rating (CDR)Timepoint: 0 days and 90 days